{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T02:03:06Z","timestamp":1760234586829,"version":"build-2065373602"},"reference-count":26,"publisher":"MDPI AG","issue":"11","license":[{"start":{"date-parts":[[2021,5,27]],"date-time":"2021-05-27T00:00:00Z","timestamp":1622073600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJERPH"],"abstract":"<jats:p>Since the dramatic rise of the coronavirus infection disease 2019 (COVID-19) pandemic, patients receiving dialysis have emerged as especially susceptible to this infection because of their impaired immunologic state, chronic inflammation and the high incidence of comorbidities. Although several strategies have thus been implemented to minimize the risk of transmission and acquisition in this population worldwide, the reported severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) seroprevalence varies across studies but is higher than in the general population. On the contrary, the screening for hepatitis viruses (HBV and HCV) has seen significant improvements in recent years, with vaccination in the case of HBV and effective viral infection treatment for HCV. In this sense, a universal SARS-CoV-2 screening and contact precaution appear to be effective in preventing further transmission. Finally, regarding the progress, an international consensus with updated protocols that prioritize between old and new indicators would seem a reasonable tool to address these unexpended changes for the nephrology community.<\/jats:p>","DOI":"10.3390\/ijerph18115748","type":"journal-article","created":{"date-parts":[[2021,5,27]],"date-time":"2021-05-27T11:07:02Z","timestamp":1622113622000},"page":"5748","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["SARS-CoV-2 vs. Hepatitis Virus Infection Risk in the Hemodialysis Population: What Should We Expect?"],"prefix":"10.3390","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0148-891X","authenticated-orcid":false,"given":"Luis","family":"D\u2019Marco","sequence":"first","affiliation":[{"name":"Nephrology Department, Hospital Cl\u00ednico Universitario (INCLIVA), 46010 Valencia, Spain"},{"name":"School of Medicine, Universidad de Valencia, 46010 Valencia, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6927-071X","authenticated-orcid":false,"given":"Mar\u00eda Jes\u00fas","family":"Puchades","sequence":"additional","affiliation":[{"name":"Nephrology Department, Hospital Cl\u00ednico Universitario (INCLIVA), 46010 Valencia, Spain"},{"name":"School of Medicine, Universidad de Valencia, 46010 Valencia, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miguel \u00c1ngel","family":"Serra","sequence":"additional","affiliation":[{"name":"School of Medicine, Universidad de Valencia, 46010 Valencia, Spain"},{"name":"Digestive Medicine Department, Hospital Cl\u00ednico Universitario de Valencia, 46010 Val\u00e8ncia, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lorena","family":"Gand\u00eda","sequence":"additional","affiliation":[{"name":"Nephrology Department, Hospital Cl\u00ednico Universitario (INCLIVA), 46010 Valencia, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sergio","family":"Romero-Alcaide","sequence":"additional","affiliation":[{"name":"Nephrology Department, Hospital Cl\u00ednico Universitario (INCLIVA), 46010 Valencia, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elena","family":"Gim\u00e9nez-Civera","sequence":"additional","affiliation":[{"name":"Nephrology Department, Hospital Cl\u00ednico Universitario (INCLIVA), 46010 Valencia, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8311-6214","authenticated-orcid":false,"given":"Pablo","family":"Molina","sequence":"additional","affiliation":[{"name":"School of Medicine, Universidad de Valencia, 46010 Valencia, Spain"},{"name":"Nephrology Department, Hospital Dr. Peset, FISABIO, 46017 Val\u00e8ncia, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nayara","family":"Panizo","sequence":"additional","affiliation":[{"name":"Nephrology Department, Hospital Cl\u00ednico Universitario (INCLIVA), 46010 Valencia, Spain"},{"name":"School of Medicine, Universidad de Valencia, 46010 Valencia, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6470-0685","authenticated-orcid":false,"given":"Javier","family":"Reque","sequence":"additional","affiliation":[{"name":"Nephrology Department, Hospital de Castell\u00f3n, 12004 Castell\u00f3n, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1134-9051","authenticated-orcid":false,"given":"Jos\u00e9 Luis","family":"Gorriz","sequence":"additional","affiliation":[{"name":"Nephrology Department, Hospital Cl\u00ednico Universitario (INCLIVA), 46010 Valencia, Spain"},{"name":"School of Medicine, Universidad de Valencia, 46010 Valencia, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2021,5,27]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1093\/ckj\/sfaa104","article-title":"Coronavirus disease 2019 in chronic kidney disease","volume":"13","author":"Puchades","year":"2020","journal-title":"Clin. Kidney J."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1001\/jamainternmed.2020.4130","article-title":"Seroprevalence of Antibodies to SARS-CoV-2 in 10 Sites in the United States, March 23\u2013May 12, 2020","volume":"180","author":"Havers","year":"2020","journal-title":"JAMA Intern. Med."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.xkme.2021.01.002","article-title":"SARS-CoV-2 Antibody Seroprevalence among Maintenance Dialysis Patients in the United States","volume":"3","author":"Walker","year":"2021","journal-title":"Kidney Med."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1111\/liv.13367","article-title":"Epidemiology update for hepatitis C virus and hepatitis B virus in end-stage renal disease in France","volume":"37","author":"Couchoud","year":"2017","journal-title":"Liver Int."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"S82","DOI":"10.1016\/j.jhep.2016.06.011","article-title":"Hepatitis C virus infection and chronic kidney disease: Time for reappraisal","volume":"65","author":"Cacoub","year":"2016","journal-title":"J. Hepatol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1053\/j.ajkd.2019.12.016","article-title":"KDOQI US Commentary on the 2018 KDIGO Clinical Practice Guideline for the Prevention, Diagnosis, Evaluation, and Treatment of Hepatitis C","volume":"75","author":"Roth","year":"2020","journal-title":"Am. J. Kidney Dis."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"2158","DOI":"10.1016\/j.cgh.2019.07.050","article-title":"Hepatitis C in Chronic Kidney Disease: An Overview of the KDIGO Guideline","volume":"18","author":"Awan","year":"2020","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1111\/j.1440-1797.2009.01268.x","article-title":"Review article: Hepatitis B and dialysis","volume":"15","author":"Edey","year":"2010","journal-title":"Nephrology"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"2222","DOI":"10.1046\/j.1523-1755.2003.00017.x","article-title":"Patterns of hepatitis B prevalence and seroconversion in hemodialysis units from three continents: The DOPPS","volume":"63","author":"Burdick","year":"2003","journal-title":"Kidney Int."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.ijid.2019.10.023","article-title":"Occult hepatitis B in kidney transplants recipients and donors from Western Mexico","volume":"91","author":"Chiquete","year":"2020","journal-title":"Int. J. Infect. Dis."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1365-2893.2009.01245.x","article-title":"Occult hepatitis B virus infection: A covert operation","volume":"17","author":"Hollinger","year":"2010","journal-title":"J. Viral Hepat."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1016\/j.gastrohep.2012.04.006","article-title":"Documento de consenso de la AEEH sobre el tratamiento de la infecci\u00f3n por el virus de la hepatitis B","volume":"35","author":"Buti","year":"2012","journal-title":"Gastroenterol. Hepatol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"S792","DOI":"10.1093\/infdis\/jix135","article-title":"Tenofovir Alafenamide Fumarate: A New Tenofovir Prodrug for the Treatment of Chronic Hepatitis B Infection","volume":"216","author":"Buti","year":"2017","journal-title":"J. Infect. Dis."},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"Garriga, C., Manzanares-Laya, S., De Olalla, P.G., Gorrindo, P., Lens, S., Sol\u00e0, R., Mart\u00ednez-Rebollar, M., Laguno, M., Navarro, J., and Torras, X. (2017). Evolution of acute hepatitis C virus infection in a large European city: Trends and new patterns. PLoS ONE, 12.","DOI":"10.1371\/journal.pone.0187893"},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"Lanini, S., Puro, V., Lauria, F.N., Fusco, F.M., Nisii, C., and Ippolito, G. (2009). Patient to patient transmission of hepatitis B virus: A systematic review of reports on outbreaks between 1992 and 2007. BMC Med., 7.","DOI":"10.1186\/1741-7015-7-15"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1681\/ASN.2020030354","article-title":"Clinical Characteristics of and Medical Interventions for COVID-19 in Hemodialysis Patients in Wuhan, China","volume":"31","author":"Xiong","year":"2020","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1016\/j.kint.2020.09.006","article-title":"Results from the ERA-EDTA Registry indicate a high mortality due to COVID-19 in dialysis patients and kidney transplant recipients across Europe","volume":"98","author":"Jager","year":"2020","journal-title":"Kidney Int."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.kint.2020.04.031","article-title":"COVID-19: Clinical course and outcomes of 36 hemodialysis patients in Spain","volume":"98","author":"Goicoechea","year":"2020","journal-title":"Kidney Int."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1815","DOI":"10.1681\/ASN.2020040534","article-title":"Epidemiology of COVID-19 in an Urban Dialysis Center","volume":"31","author":"Corbett","year":"2020","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1038\/s41586-020-2521-4","article-title":"Factors associated with COVID-19-related death using OpenSAFELY","volume":"584","author":"Williamson","year":"2020","journal-title":"Nature"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1038\/s41581-020-00349-4","article-title":"CKD is a key risk factor for COVID-19 mortality","volume":"16","author":"Gansevoort","year":"2020","journal-title":"Nat. Rev. Nephrol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"690.e1","DOI":"10.1053\/j.ajkd.2020.07.001","article-title":"COVID-19 Outbreak in an Urban Hemodialysis Unit","volume":"76","author":"Yau","year":"2020","journal-title":"Am. J. Kidney Dis."},{"key":"ref_23","doi-asserted-by":"crossref","unstructured":"D\u2019Marco, L., Puchades, M.J., Romero-Parra, M., and Gorriz, J.L. (2020). Diabetic Kidney Disease and COVID-19: The Crash of Two Pandemics. Front. Med., 7.","DOI":"10.3389\/fmed.2020.00199"},{"key":"ref_24","doi-asserted-by":"crossref","unstructured":"Quiroga, B., Mu\u00f1oz Ramos, P., Giorgi, M., de Santos, A., N\u00fa\u00f1ez, A., Ortiz, A., Redondo Polo, C., Almer\u00eda G\u00f3mez, O., Marcos-Jim\u00e9nez, A., and Esparcia Pinedo, L. (2021). Dynamic assessment of interleukin-6 during hemodialysis and mortality in coronavirus disease-19. Ther. Apher. Dial.","DOI":"10.1111\/1744-9987.13626"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1055\/a-1375-4471","article-title":"SARS-CoV-2-Impfungen\u2014Was muss der Nephrologe wissen?","volume":"146","author":"Heine","year":"2021","journal-title":"Dtsch. Med. Wochenschr."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1016\/j.kint.2021.03.014","article-title":"Weak anti\u2013SARS-CoV-2 antibody response after the first injection of an mRNA COVID-19 vaccine in kidney transplant recipients","volume":"99","author":"Benotmane","year":"2021","journal-title":"Kidney Int."}],"container-title":["International Journal of Environmental Research and Public Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1660-4601\/18\/11\/5748\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T06:08:53Z","timestamp":1760162933000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1660-4601\/18\/11\/5748"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5,27]]},"references-count":26,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2021,6]]}},"alternative-id":["ijerph18115748"],"URL":"https:\/\/doi.org\/10.3390\/ijerph18115748","relation":{},"ISSN":["1660-4601"],"issn-type":[{"type":"electronic","value":"1660-4601"}],"subject":[],"published":{"date-parts":[[2021,5,27]]}}}